The global pharmaceutical filtration market is expected to enjoy a valuation of US$ 17.8 Bn by the end of 2022 and further expand at a CAGR of 8.7% to reach a valuation of ~US$ 41.0 Bn by 2032. According to the recent study, membrane filters segment by product is leading the market with a share of about 33.3% in 2021. Active pharmaceutical ingredients are a …
Category Archives: Healthcare Trends
Liquid Biopsy Market to expand at a 13.49% value CAGR by 2032 | FMI projects
The global liquid biopsy market is anticipated to create lucrative growth opportunities over the projection period by exhibiting a total CAGR of 13.49% from 2022 to 2032. The global market is expected to be valued at US$ 1,146 Million in 2022 and surpass a valuation of around US$ 4,126 Million in 2032. The growth of …
Continue reading “Liquid Biopsy Market to expand at a 13.49% value CAGR by 2032 | FMI projects”
Eye Tracking System Market is expected to reach a valuation of US$ 4.9 billion by 2028 | FMI
The global Eye Tracking System Market is anticipated to reach a value of US$ 1.2 billion in 2022 and is projected to close in on US$ 4.9 billion by 2028, growing quickly at a CAGR of 26.6% between 2022 and 2028. Eye-tracking systems are therefore a key amalgamation of software and hardware which allows allowing …
Esophagoscopes & Gastroscopes Market are estimated to attain a valuation of US$ 2.0 billion by 2033
The global Esophagoscopes & Gastroscopes Market currently stands at US$ 1.2 billion and is predicted to exhibit a CAGR of 5.4%. The market is predicted to attain a valuation of US$ 2.0 billion by the end of 2033. Technological Innovations Work in Market’s Favor Innovations in the medical sector have led to a rise in …
Antidepressants to Procure 48% Market Share for Generalized Anxiety Disorder Treatment Market | FMI Study
During the forecast period 2023 to 2033, the Generalized anxiety disorder treatment market is expected to grow at a value of 9% CAGR, according to Future Market Insights. By the year 2033, the global market for Generalized anxiety disorder treatment market is expected to rise up to a market valuation of US$ 4261.25 Million. Growth …
Increasing Incidence of CNS Disorders to Propel the Growth of Market at 30% CAGR through 2033 | FMI Study
The growing pipeline of gene therapy treatments for CNS disorders is expected to drive the growth of the gene therapy in CNS disorder market in the coming years. According to a report by Future Market Insights, the global gene therapy in CNS disorder market is expected to grow at a compound annual growth rate (CAGR) …
Oral Route Medications to Procure 55% Market Share for Castration-Resistant Prostate Cancer (CRPC) Treatment Market | FMI Study
During the forecast period 2023 to 2033, the Castration-Resistant Prostate Cancer (CRPC) Treatment market is expected to grow at a value of 9.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Castration-Resistant Prostate Cancer (CRPC) Treatment is expected to rise up to a market valuation of US$ 28 Billion. …
Increasing Incidence of Cocaine Intoxication to Propel the Growth of Market at 6% CAGR through 2033 | FMI Study
The cocaine intoxication treatment market is expected to experience significant growth in the coming years as the prevalence of cocaine addiction continues to rise. According to a report by Future Market Insights, the global cocaine intoxication treatment market is projected to grow at a CAGR of 6% from 2023 to 2033, surpassing an impressive valuation …
Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market to Register 4.9% CAGR from 2023 to 2033 | FMI Study
During the forecast period 2023 to 2033, the atypical hemolytic uremic syndrome (ahus) treatment market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Atypical hemolytic uremic syndrome (ahus) treatment is expected to rise up to a market valuation of US$ …
High Potency API Contract Manufacturing Value to reach US$ 8 Billion by 2032; Oncology to account for over 60% Applications
A recently published study by FMI expects the global high potency API contract manufacturing market to augment at a 7% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 8 Billion is expected for the market. Rising breakthroughs in high potency API (HPAPI) manufacturing technologies, combined with …